Glycopolysialylation of non-blood coagulation proteins

US9795683B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9795683-B2
Application numberUS-84328410-A
CountryUS
Kind codeB2
Filing dateJul 26, 2010
Priority dateJul 27, 2009
Publication dateOct 24, 2017
Grant dateOct 24, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A water soluble polymer, in particular polysialic acid (PSA) or a modified PSA (mPSA), is conjugated to an oxidized carbohydrate moiety of a glycoprotein other than a blood coagulation protein or to a ganglioside or drug delivery system by contacting the oxidized carbohydrate moiety with the water soluble polymer, wherein said water soluble polymer contains an aminooxy group and an oxime linkage is formed between the oxidized carbohydrate moiety and the aminooxy group on the water soluble polymer or wherein said water soluble polymer contains a hydrazide group and a hydrazone linkage is formed between the oxidized carbohydrate moiety and the hydrazide group on the water soluble polymer. Conjugates of aminooxy- or hydrazide-water soluble polymer, such as PSA and mPSA, are thus obtained in which the PSA or mPSA is attached via a carbohydrate moiety.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method of conjugating a polysialic acid (PSA) or a modified PSA (mPSA) to an oxidized carbohydrate moiety on a polypeptide with DNase activity, comprising contacting the oxidized carbohydrate moiety with the PSA or mPSA under conditions that allow conjugation, wherein said PSA or mPSA contains an aminooxy group and an oxime linkage is formed between the oxidized carbohydrate moiety and the aminooxy group on the PSA or mPSA; and wherein said polypeptide has a specific activity of at least 80% relative to an unmodified polypeptide. 2. The method of claim 1 wherein the PSA or mPSA is colominic acid or modified colominic acid. 3. The method of claim 1 wherein the PSA or mPSA comprises 10-300 sialic acid units. 4. The method of claim 1 , further comprising oxidizing the carbohydrate moiety by incubating said polypeptide with sodium periodate (NaIO 4 ). 5. The method of claim 1 , further comprising oxidizing the PSA or mPSA to form an aldehyde group on a terminal unit of the PSA or mPSA, and reacting the oxidized PSA or mPSA with an aminooxy linker. 6. The method of claim 5 comprising oxidizing the PSA or mPSA using NaIO 4 . 7. The method of claim 1 wherein said contacting the oxidized carbohydrate moiety with PSA or mPSA occurs in a buffer comprising a nucleophilic catalyst selected from the group consisting of aniline and aniline derivatives. 8. The method of claim 1 wherein the aminooxy group is formed by reacting oxidized PSA or mPSA with an aminooxy linker selected from the group consisting of 3- oxa-pentane-1,5 -dioxyamine and 3,6, 9-trioxa-undecane-1, 11-dioxyamine. 9. The method of claim 1 further comprising reducing an oxime linkage said polypeptide by incubation in the presence of a reducing compound. 10. The method according to claim 9 wherein the reducing compound is sodium cyanoborohydride (NaCNBH 3 ) or ascorbic acid (vitamin C). 11. A conjugated polypeptide with DNase activity, comprising: (a) a polypeptide with DNase activity; and (b) at least one aminooxy-PSA or aminooxy-mPSA bound to the polypeptide of (a), wherein said aminooxy-PSA or aminooxy-mPSA is attached to the polypeptide via one or more oxidized carbohydrate moieties; and wherein said polypeptide has a specific activity of at least 80% relative to an unmodified polypeptide.

Assignees

Inventors

Classifications

  • Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers · CPC title

  • Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids · CPC title

  • A61K47/60Primary

    the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol · CPC title

  • Carbohydrates; Sugars; Derivatives thereof (sorbitol A61K31/047) · CPC title

  • the organic macromolecular compound being a polysaccharide or a derivative thereof · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9795683B2 cover?
A water soluble polymer, in particular polysialic acid (PSA) or a modified PSA (mPSA), is conjugated to an oxidized carbohydrate moiety of a glycoprotein other than a blood coagulation protein or to a ganglioside or drug delivery system by contacting the oxidized carbohydrate moiety with the water soluble polymer, wherein said water soluble polymer contains an aminooxy group and an oxime linkag…
Who is the assignee on this patent?
Jain Sanjay, Gregoriadis Gregory, Dwivedi Archana, and 8 more
What technology area does this patent fall under?
Primary CPC classification A61K47/6455. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 24 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).